CADENCE PHARMACEUTICALS INC R3 - 12738T100
Sector:
No information yet
· Industry:
No information yet
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2014
· Q4 2013
Value (USD)
Total reported value ($000)
$8.563M
QoQ value delta ($000)
-$398.9M
(-97.9%)
Implied price effect (QoQ)
+34.45%
Shares
Total shares
797,013
QoQ shares delta
-50,195,862
(-98.44%)
Total shares held by funds (by quarter)
Top holders (Q1 2014)
Top 25 only
Full list
Partial Q1 2014 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| NORGES BANK | 4,336 | 479,154 | 0.0% |
| OMNI PARTNERS LLP | 3,500 | 250,000 | 5.2% |
| CONNOR CLARK & LUNN INVESTMENT MANAGEMENT LTD | 309 | 32,119 | 0.0% |
| CITIGROUP INC | 183 | 13,052 | 0.0% |
| Jane Street Holding, LLC | 149 | 16,510 | 0.0% |
| BlackRock Institutional Trust Company, N.A. | 86 | 6,178 | 0.0% |